financetom
Business
financetom
/
Business
/
Market Chatter: JPMorgan Limits Dealings With Segantii Amid Insider-Trading Case
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: JPMorgan Limits Dealings With Segantii Amid Insider-Trading Case
May 8, 2024 6:10 AM

08:36 AM EDT, 05/08/2024 (MT Newswires) -- JPMorgan Chase ( JPM ) is limiting its exposure to Segantii Capital Management after the Asian hedge fund was charged with insider trading by Hong Kong authorities, Bloomberg reported late Tuesday, citing people familiar with the matter.

JPMorgan ( JPM ) will not engage with Segantii on new block trades or initial public offerings, the people were quoted as saying.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 191.00, Change: -0.75, Percent Change: -0.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Mar 10, 2026
Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio Transaction anticipated to be accretive to Genmab’s EBITDA by end of 2029   COPENHAGEN, Denmark--(BUSINESS WIRE)-- Genmab A/S ( GMAB ) (“Genmab”) announced today that the conditions, including the minimum tender condition, to the previously announced tender offer (the “Offer”) by Genmab Holding II...
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Mar 10, 2026
Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolioTransaction anticipated to be accretive to Genmab’s EBITDA by end of 2029 COPENHAGEN, Denmark; December 12, 2025 – Genmab A/S ( GMAB ) (“Genmab”) announced today that the conditions, including the minimum tender condition, to the previously announced tender offer (the “Offer”) by Genmab Holding...
Novo Nordisk launches blockbuster diabetes drug Ozempic in India
Novo Nordisk launches blockbuster diabetes drug Ozempic in India
Mar 10, 2026
Dec 12 (Reuters) - Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday. Ozempic, a once-weekly injectable approved by the U.S. Food and Drug Administration in 2017 for type 2 diabetes, has become a global bestseller and is widely used off-label for weight loss due to its appetite-suppressing effects. ...
Australia unveils rescue bid for Rio Tinto's Tomago aluminium smelter
Australia unveils rescue bid for Rio Tinto's Tomago aluminium smelter
Mar 10, 2026
SYDNEY, Dec 12 (Reuters) - Prime Minister Anthony Albanese announced on Friday a rescue effort to keep open Australia's largest aluminium smelter, the struggling Tomago facility majority-owned by Rio TintoAX>, after its current power contract expires in 2028. The news comes after the company warned in October that Tomago Aluminium, employer of more than 1,000 full-time staff and 200 contractors,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved